PRESTIGE ANTIBODIES
Live / Registered — Registered and renewed (as of 21 Apr 2018)
What this means for you
Registered since 18 Nov 2008. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 18 Nov 2018).
Record
- Serial number
- 77374126
- Registration number
- 3535214
- Mark type
- Stylized text
- Filed
- 17 Jan 2008
- Published for opposition
- 03 Jun 2008
- Registered
- 18 Nov 2008
- Next maintenance due
- 18 Nov 2018
- Attorney of record
- William C. Wright
Goods and services
- Class 001 — Chemicals: Chemical and biological antibodies and reagents all for research use, scientific diagnostic use, diagnostic research use, diagnostic medical research use, industrial scientific use, industrial research use, use in industrial manufacturing processes, laboratory research use and scientific use
Owner
- MERCK KGAA, DARMSTADT, DE
- SIGMA-ALDRICH CO., LLC, St. Louis, MO, US
- Sigma-Aldrich Biotechnology L.P., St. Louis, MO, US
- Sigma-Aldrich Biotechnology L.P., St. Louis, MO, US
- Sigma-Aldrich Biotechnology L.P., St. Louis, MO, US
Prosecution history
- 20 May 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 May 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 May 2021 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 20 May 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 May 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 May 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 28 Oct 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 21 Apr 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 21 Apr 2018 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 21 Apr 2018 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 21 Apr 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Apr 2018 — TEAS SECTION 8 & 9 RECEIVED
- 10 Apr 2018 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Nov 2017 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 26 Nov 2014 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED